Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

indomethacin nanopowder dispersion

Based on

2 Patents
2015 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetic acid)

3-indoleacetic acid indomethacin indometacin IndOH IMC IND
Type Single Compound
Formula C19H16ClNO4
Role raw materials

Properties

Applications

Characterization

Method Source
dynamic light scattering

0 more entry available to subscribers only.

Or, view sample content

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • (1-(4-chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetic acid)
  • polyethylene glycol 400
  • fructose
Product

indomethacin nanopowder dispersion

Method 2

Type: Physical formation
Source:
Starting materials
  • hypodicarbonous acid
  • (1-(4-chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetic acid)
  • trehalose
Product

indomethacin nanopowder dispersion

Method 3

Type: Physical formation
Source:
Starting materials
  • (1-(4-chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetic acid)
  • 1,2,3-trihydroxypropane
  • D-(-)-mannitol
See all (4)
Product

indomethacin nanopowder dispersion

Method 4

Type: Physical formation
Source:
Starting materials
  • hypodicarbonous acid
  • (1-(4-chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetic acid)
  • trehalose
Product

indomethacin nanopowder dispersion

Method 5

Type: Physical formation
Source:
Starting materials
  • (1-(4-chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetic acid)
  • 1,2,3-trihydroxypropane
  • D-(-)-mannitol
See all (4)
Product

indomethacin nanopowder dispersion

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial